Laboratory Medicine ›› 2019, Vol. 34 ›› Issue (3): 282-284.DOI: 10.3969/j.issn.1673-8640.2019.03.022
Received:2018-01-17
Online:2019-03-30
Published:2019-03-27
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2019.03.022
| [1] | FICHT T.Brucella taxonomy and evolution[J]. Future Microbiol,2010,5(6):859-866. |
| [2] | CORBELL M J.Brucellosis:epidemiology and prevalence worldwide[J]. Boca Raton: CRC Press,1989:25-40. |
| [3] | GAO G,WANG Y,CHEN Z,et al.Brucella virulence mechanisms and implications in novel vaccines and drugs[J]. Crit Rev Eukaryot Gene Expr,2013,23(1):49-64. |
| [4] | MACHELART A,POTEMBERG G,VAN MAELE L,et al.Allergic asthma favors Brucella growth in the lungs of infected mice[J]. Front Immunol, 2018, 9: 1856. |
| [5] | YIN X H,LIU Z K,HE B R,et al.One-stage surgical management for lumber brucella spondylitis with anterior debridement,autogenous graft,and instrumentation[J]. Medicine (Baltimore),2018,97(30):e11704. |
| [6] | GAROFOLO G, FASANELLA A, DI GIANNATALE E,et al.Cases of human brucellosis in Sweden linked to Middle East and Africa[J]. BMC Res Notes,2016,9:277. |
| [7] | MCELWAIN T F,THUMBI S M.Animal pathogens and their impact on animal health,the economy,food security, food safety and public health[J]. Rev Sci Tech,2017,36(2):423-433. |
| [8] | 马淑青,袁晓明. 4例布鲁菌感染病例分析[J]. 检验医学,2018,33(2):188-190. |
| [9] | MANI S S R,GUNASEKARAN K,IYYADURAI R,et al. Clinical spectrum,susceptibility profile,treatment and outcome of culture-confirmed brucellosis from South India[J]. Indian J Med Microbiol, 2018, 36(2): 289-292. |
| [10] | SONG K J,YOON S J,LEE K B. Cervical spinal brucellosis with epidural abscess causing neurologic deficit with negative serologic tests[J]. World Neurosurg,2012,78(3-4):375. e15-e19. |
| [11] | Clinical and Laboratory Standards Institute. Principles and procedures for blood cultures[S]. M47-A,CLSI,2007. |
| [1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
| [2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
| [3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
| [4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
| [5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
| [6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
| [7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
| [8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
| [9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
| [10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
| [11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
| [12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
| [13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
| [14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
| [15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
